A.K. PHARMA: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
A.K. PHARMA
Largest movements
- Receivables within one year -€94,666
down €94,666 (-22.4%), from €422,764 to €328,098
of which Trade receivables: -€93,137
- Cash +€42,547
up €42,547 (+33.2%), from €128,038 to €170,585
mainly Receivables within one year (+€94,666) and Net result for the year (+€72,703)
- Trade debts -€120,137
down €120,137 (-25.2%), from €477,392 to €357,255
- Reserves +€57,000
up €57,000 (+380.0%), from €15,000 to €72,000
of which Distributable reserves: +€57,000
- Tax, wage and social debts +€18,097
up €18,097 (+15.0%), from €120,497 to €138,595
of which Taxes: +€31,318
- Debts after one year -€14,281
down €14,281 (-72.6%), from €19,681 to €5,400
of which Financial debts: -€14,281
- Staff costs +€32,419
up €32,419 (+12.7%), from €256,080 to €288,499
- Gross operating margin +€26,830
up €26,830 (+6.5%), from €415,873 to €442,703
- Other operating charges +€17,909
up €17,909 (+107.2%), from €16,706 to €34,616
- Taxes -€12,355
down €12,355 (-24.7%), from €50,074 to €37,718
From the 2023 result to the 2024 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2023 and 2024 balance sheets and the 2024 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2023 | 2024 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €912,209 | €857,382 | -€54,826 | -6.0% |
| Fixed assets | 21/28 | €21,804 | €17,253 | -€4,551 | -20.9% |
| Tangible fixed assets | 22/27 | €21,624 | €17,073 | -€4,551 | -21.0% |
| Plant, machinery and equipment | 23 | €181 | - | -€181 | |
| Furniture and vehicles | 24 | €20,541 | €16,713 | -€3,828 | -18.6% |
| Other tangible fixed assets | 26 | €902 | €360 | -€543 | -60.1% |
| Financial fixed assets | 28 | €180 | €180 | = | 0.0% |
| Current assets | 29/58 | €890,404 | €840,129 | -€50,275 | -5.6% |
| Amounts receivable after more than one year | 29 | €250,000 | €250,000 | = | 0.0% |
| Trade receivables | 290 | €150,000 | €150,000 | = | 0.0% |
| Other amounts receivable | 291 | €100,000 | €100,000 | = | 0.0% |
| Stocks and contracts in progress | 3 | €82,968 | €85,122 | +€2,154 | +2.6% |
| Stocks | 30/36 | €82,968 | €85,122 | +€2,154 | +2.6% |
| Amounts receivable within one year | 40/41 | €422,764 | €328,098 | -€94,666 | -22.4% |
| Trade receivables | 40 | €413,225 | €320,088 | -€93,137 | -22.5% |
| Other amounts receivable | 41 | €9,539 | €8,010 | -€1,529 | -16.0% |
| Cash at bank and in hand | 54/58 | €128,038 | €170,585 | +€42,547 | +33.2% |
| Deferred charges and accrued income | 490/1 | €6,634 | €6,325 | -€310 | -4.7% |
| Total equity and liabilities | 10/49 | €912,209 | €857,382 | -€54,826 | -6.0% |
| Equity | 10/15 | €274,205 | €331,908 | +€57,703 | +21.0% |
| Contributions | 10/11 | €18,600 | €18,600 | = | 0.0% |
| Capital | 10 | €18,600 | €18,600 | = | 0.0% |
| Issued capital | 100 | €19,000 | €19,000 | = | 0.0% |
| Uncalled capital | 101 | €400 | €400 | = | 0.0% |
| Reserves | 13 | €15,000 | €72,000 | +€57,000 | +380.0% |
| Tax-exempt reserves | 132 | €15,000 | €15,000 | = | 0.0% |
| Distributable reserves | 133 | - | €57,000 | +€57,000 | |
| Profit (loss) carried forward | 14 | €240,605 | €241,308 | +€703 | +0.3% |
| Amounts payable | 17/49 | €638,004 | €525,474 | -€112,530 | -17.6% |
| Amounts payable after more than one year | 17 | €19,681 | €5,400 | -€14,281 | -72.6% |
| Financial debts | 170/4 | €14,281 | - | -€14,281 | |
| Other amounts payable | 178/9 | €5,400 | €5,400 | = | 0.0% |
| Amounts payable within one year | 42/48 | €618,323 | €520,074 | -€98,249 | -15.9% |
| Trade debts | 44 | €477,392 | €357,255 | -€120,137 | -25.2% |
| Suppliers | 440/4 | €477,392 | €357,255 | -€120,137 | -25.2% |
| Taxes, remuneration and social security | 45 | €120,497 | €138,595 | +€18,097 | +15.0% |
| Taxes | 450/3 | €75,436 | €106,754 | +€31,318 | +41.5% |
| Remuneration and social security | 454/9 | €45,061 | €31,841 | -€13,221 | -29.3% |
| Other amounts payable | 47/48 | €20,434 | €24,225 | +€3,790 | +18.5% |
| Remuneration, social security and pensions | 62 | €256,080 | €288,499 | +€32,419 | +12.7% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €4,860 | €4,551 | -€309 | -6.4% |
| Other operating charges | 640/8 | €16,706 | €34,616 | +€17,909 | +107.2% |
| Non-recurring operating charges | 66A | €148 | - | -€148 | |
| Gross operating margin | 9900 | €415,873 | €442,703 | +€26,830 | +6.5% |
| Operating profit (loss) | 9901 | €138,078 | €115,037 | -€23,041 | -16.7% |
| Financial income | 75/76B | €297 | €145 | -€152 | -51.1% |
| Recurring financial income | 75 | €297 | €129 | -€168 | -56.5% |
| Non-recurring financial income | 76B | - | €16 | +€16 | |
| Financial charges | 65/66B | €6,064 | €4,761 | -€1,303 | -21.5% |
| Recurring financial charges | 65 | €6,064 | €4,761 | -€1,303 | -21.5% |
| Profit (loss) for the period before taxes | 9903 | €132,311 | €110,422 | -€21,889 | -16.5% |
| Income taxes | 67/77 | €50,074 | €37,718 | -€12,355 | -24.7% |
| Profit (loss) for the period | 9904 | €82,237 | €72,703 | -€9,534 | -11.6% |
| Profit (loss) for the period to be appropriated | 9905 | €82,237 | €72,703 | -€9,534 | -11.6% |
Source: filed annual accounts (NBB), fiscal years ended 31 December 2023 and 31 December 2024. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 4 October 2026 via checked.be.